BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human PPARγ1 (3-108 aa) and mouse myelomacells (NS-1)
Produced in BALB/c mouse ascites after inoculation with hybridoma of mouse myeloma cells (NS-1) and spleen cells derived from a BALB/c mouse immunized with Baculovirusexpressed recombinant mouse G9a (15-114aa).
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human REVERBα (2-130 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human FXR (2-126 aa) and mouse myelomacells (NS-1)
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human PR isoform A (2-99 aa) and mouse myelomacells (NS-1)
Produced in BALB/c mouse ascites after inoculation with hybridoma of mouse myeloma cells (NS-1) and spleen cells derived from a BALB/c mouse immunized with Baculovirusexpressed recombinant mouse GLP (134-234 aa).
Produced in BALB/c mouse ascites after inoculation with hybridoma of mouse myeloma cells (NS-1) and spleen cells derived from a BALB/c mouse immunized with Baculovirusexpressed recombinant human HNF4 γ (91-212 aa).
BALB/c mouse ascites inoculated with hybridoma of spleen cells of BALB/c mouse immunized with recombinant human TR2 (4-110 aa) and mouse myelomacells (NS-1)
Produced in BALB/c mouse ascites after inoculation with hybridoma of mouse myeloma cells (NS-1) and spleen cells derived from a BALB/c mouse immunized with Baculovirus-expressed recombinant human TR4 (23-52 aa)
Produced in BALB/c mouse ascites after inoculation with hybridoma of mouse myeloma cells (NS-1) and spleen cells derived from a BALB/c mouse immunized with Baculovirusexpressed recombinant human PXR-2 (1-78 aa).